Cargando…

Base Editing of Human Pluripotent Stem Cells for Modeling Long QT Syndrome

Human pluripotent stem cells (hPSCs) have great potential for disease modeling, drug discovery, and regenerative medicine as they can differentiate into many different functional cell types via directed differentiation. However, the application of disease modeling is limited due to a time-consuming...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Fujian, Guo, Tianwei, Sun, Lixiang, Li, Furong, Yang, Xiaofei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033722/ https://www.ncbi.nlm.nih.gov/pubmed/34997921 http://dx.doi.org/10.1007/s12015-021-10324-6

Ejemplares similares

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
por: Sala, Luca, et al.
Publicado: (2019)

Base Editing Mediated Generation of Point Mutations Into Human Pluripotent Stem Cells for Modeling Disease
por: Qi, Tao, et al.
Publicado: (2020)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A(±))
por: Ge, Ning, et al.
Publicado: (2023)

Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells
por: Yoshinaga, Daisuke, et al.
Publicado: (2019)

Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model
por: Hirose, Sayako, et al.
Publicado: (2020)

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
por: Bellin, Milena, et al.
Publicado: (2013)

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes
por: Matsa, Elena, et al.
Publicado: (2014)

Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome
por: Shiti, Assad, et al.
Publicado: (2023)

Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Song, Yongfei, et al.
Publicado: (2022)

Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
por: Stillitano, Francesca, et al.
Publicado: (2017)

Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells
por: Belbachir, Nadjet, et al.
Publicado: (2023)

Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics
por: Terrenoire, Cecile, et al.
Publicado: (2013)

QT Adaptation and Intrinsic QT Variability in Congenital Long QT Syndrome
por: Seethala, Srikanth, et al.
Publicado: (2015)

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
por: Matsa, Elena, et al.
Publicado: (2011)

The Long QT Syndrome
por: Vincent, G. Michael
Publicado: (2002)

“Thorough QT/QTc in a Dish”: Can Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Predict Thorough QT Outcomes?
por: Vargas, Hugo M.
Publicado: (2019)

Genome editing of human pluripotent stem cells to generate human cellular disease models
por: Musunuru, Kiran
Publicado: (2013)

A review of protocols for engineering human cardiac organoids
por: Wu, Fujian, et al.
Publicado: (2023)

Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2021)

The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients
por: Fatima, Azra, et al.
Publicado: (2013)

Congenital long QT syndrome
por: Crotti, Lia, et al.
Publicado: (2008)

KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation
por: Song, Yuanxiu, et al.
Publicado: (2022)

Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2022)

Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes
por: Paci, Michelangelo, et al.
Publicado: (2018)

When Long Noncoding RNAs Meet Genome Editing in Pluripotent Stem Cells
por: Chen, Fuquan, et al.
Publicado: (2017)

iPSC-derived model of long QT syndrome
Publicado: (2012)

Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells
por: Li, Mu, et al.
Publicado: (2022)

Protocol for the design, conduct, and evaluation of prime editing in human pluripotent stem cells
por: Wu, Youjun, et al.
Publicado: (2023)

Generation of an ICF Syndrome Model by Efficient Genome Editing of Human Induced Pluripotent Stem Cells Using the CRISPR System
por: Horii, Takuro, et al.
Publicado: (2013)

Gene Editing in Human Pluripotent Stem Cells: Choosing the Correct Path
por: Singh, Amar M., et al.
Publicado: (2015)

Management of Patients with Long QT Syndrome
por: Cho, Yongkeun
Publicado: (2016)

T-wave alternans in long QT syndrome
por: Gadage, Siddharth Narayan
Publicado: (2018)

Management of patients with long QT syndrome
por: Cay, Serkan, et al.
Publicado: (2017)

Pain medication and long QT syndrome
por: Klivinyi, Christoph, et al.
Publicado: (2018)

The impact of age on long QT syndrome
por: Guettler, Norbert, et al.
Publicado: (2019)

Long QT syndrome – Bench to bedside
por: Ponce-Balbuena, Daniela, et al.
Publicado: (2021)

Vonoprazan‐associated long QT syndrome
por: Kubo, Kimitoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h9q3and6etm5t0mtjkvrmdeuk8